Pancreatic Islet Cell Transplantation Act of 2003

Bill: 108-hr-1068
Sponsor: Rep. Nethercutt, George R., Jr. [R-WA-5]
Introduced: 2003-03-04 in the House
Policy area: Health
Subjects: Accreditation (Medical care)
Administrative procedure
Blood diseases
Cardiovascular diseases
Caregivers
Child health
Clinical trials
Communication in medicine
Communication in science
Congress
Congressional reporting requirements
Cost effectiveness
Department of Health and Human Services
Diabetes
Donation of organs, tissues, etc.
Economics and Public Finance
Executive reorganization
Eye diseases
Families
Federal advisory bodies
Federal aid to health facilities
Federal aid to research
Finance and Financial Sector
Government Operations and Politics
Governmental investigations
Insulin
Labor and Employment
Labor productivity
Law
Legislation
Medical economics
Medical research
Medicare
Nervous system diseases
Quality of life
Research grants
Science, Technology, Communications
Sick leave
Social Welfare
Transplantation of organs, tissues, etc.

Summary:
action_date: 2003-03-04
text: Pancreatic Islet Cell Transplantation Act of 2003 - Amends the Public Health Service Act to include pancreases procured by an organ procurement organization and used for islet cell transplantation or research to be counted toward organ procurement organization certification.
Establishes the Interagency Committee on Islet Cell Transplantation within the Department of Health and Human Services (HHS). Requires the Committee to study related issues, including Federal research funding, the effect of specified policies on transplantation, and data collection.
Instructs the Secretary of HHS to request the Institute of Medicine to provide a study of the impact of islet cell transplantation on juvenile diabetes patients, including their health and the treatment's cost-effectiveness.
Directs the Secretary, acting through the Administrator of the Centers for Medicare & Medicaid Services, to establish a demonstration project to assess the efficacy of pancreatic cell islet transplantation for individuals who: (1) have Type I (juvenile) diabetes; and (2) have end-stage renal disease; and (3) are Medicare beneficiaries. Establishes reporting requirements.

Legislative actions:
action_date: 2003-03-14
text: Referred to the Subcommittee on Health.
action_date: 2003-03-04
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2003-03-04
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2003-03-04
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2003-03-04
text: Sponsor introductory remarks on measure. (CR E352-353)
action_date: 2003-03-04
text: Introduced in House
action_date: 2003-03-04
text: Introduced in House